Data quality assurance and quality control measures in large multicenter stroke trials: The African-American Antiplatelet Stroke Prevention Study (AAASPS) experience

Current Controlled Trials in Cardiovascular Medicine

Volumn 2, Issue 3, 2001, Pages 115-117

  Richardson, DeJuran ^a,b   Chen, Shande ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b LAKE FOREST COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

CARDIOVASCULAR DISEASE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HEALTH SERVICE; HEART INFARCTION; HUMAN; INFORMATION PROCESSING; MEDICAL AUDIT; MONITORING; MULTICENTER STUDY; NEGRO; NOTE; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; STAFF TRAINING; STROKE; TELEPHONE;

EID: 0034948561     PISSN: 14686708     EISSN: None     Source Type: Journal    
DOI: 10.1186/cvm-2-3-115     Document Type: Note

References (4)

1. Perspectives on scientific misconduct and fraud in clinical trials
2. Data quality assurance, monitoring, and reporting
3. African-American Antiplatelet Stroke Prevention Study (AAASPS): Clinical trial design